It may not be long until healthcare includes integrated AI forms...
Category:
Health
Latest
Rising Covid cases: Health Ministry asks states to maintain ‘constant vigil’
Looking at the upcoming festive season, the Union Health Secretary...
Bima Sugam: Insurers select E&Y as a consultant, new company and CEO soon to implement the project
Going by the earlier plans, Bima Sugam, built with a budget of Rs...
UK government set for leading role in insuring live entertainment
After months of closure or pared back performances with reduced audiences to allow social distancing, planning ahead to revive the sector is all but impossible without events cancellation insurance, theatre and music directors say. That makes government intervention crucial if the commercial sector will not pay.
SC directs NDMA to issue norms for financial help to kin of Covid victims
A special bench of Justices Ashok Bhushan and M R Shah said that the court cannot direct the Centre to fix a particular amount of financial help but the government can fix the minimum standard of amount to be paid as ex-gratia to family members of those who lost their lives due to COVID-19 while keeping various aspects in mind.
The top court asked the Centre to consider formulating an insurance scheme for cremation workers as proposed by the Finance Commission.
It also directs the authorities to issue appropriate guidelines for simplification of process of issuance of death certificates for Covid fatalities.
Emerging Asia: a $3.8 trillion-per-year pension savings gap
“The shortfall in saving for adequate and sustainable retirements cannot be bridged solely by government resources. Strong partnership between the state, the private sector and individuals will be key.Protecting people throughout their saving lifecycle has the potential to reduce poverty, ill-health and even social unrest, and should form a core building block of emerging markets’ longterm economic growth,” ,” said Jerome Jean Haegeli,Group Chief Economist, Swiss Re
COVID-19 in children often asymptomatic, 2pc-3 pc infected kids may require hospitalisation: VK Paul
Dr Randeep Guleria, Director of All India Institute of Medical Sciences (AIIMS) New Delhi has said that there is no data, either from India or globally, to show that children will be seriously infected in subsequent waves.
India asks EU member states to consider Covishield, Covaxin vaccines under Green Pass scheme
India has requested the EU member nations to accept the vaccination certificate issued through the CoWIN portal.
The European Union”s Digital COVID certificate or “Green Pass” will be rolled out on Thursday with an aim to facilitate free movement during the COVID-19 pandemic is to come into effect on Thursday.
Highly transmissible Covid Delta variant detected in 96 countries, says WHO
Furthermore, a recent study conducted in Scotland and published in the international medical journal Lancet found that the hospitalization rate for patients infected with the Delta variant of COVID-19 was 85 per cent higher than for those infected with the Alpha variant.
“This particular Delta variant is faster, it is fitter, it will pick off the more vulnerable more efficiently than previous variants,” Michael Ryan, executive director of the WHO’s Health Emergencies Program, has commented recently.
17 pc dip in average fresh COVID-19 cases since 2nd Corona wave peak in May, says Union Health Ministry
The Union Health Ministry further added that a total of 51 Delta plus variant cases reported in India. In regard to the Moderna COVID-19 vaccine, Dr VK Paul, Member-Health of Niti Aayog said, “New drug permission has been granted to Moderna, the first internationally developed vaccine. This new drug permission is for restricted use.”
Cipla gets DCGI nod to import Moderna’s COVID-19 vaccine for restricted emergency use in India: Sources
According to the sources, approval is likely anytime as the Central Drugs Standard Control Organisation (CDSCO) is in favor of granting permission to Cipla for import of Moderna’s COVID-19 vaccine for restricted emergency use in India considering the pandemic situation in the country and the public interest.
Johnson & Johnson exploring ways to accelerate delivery of its COVID vaccine in India
‘We are in ongoing discussions with the Government of India and are exploring how best to accelerate our ability to deliver the Johnson & Johnson single dose COVID-19 vaccine to the people of India,” Johnson & Johnson India spokesperson said in a statement.
As per the recent announcement by the Drugs Controller General of India (DCGI), there is no longer a requirement to conduct bridging clinical studies of COVID-19 vaccines in India, the statement added.
Five Indian drugmakers to jointly start local trial of Merck & Co’s COVID-19 drug
Between March and April, each of these companies, including Sun Pharmaceutical Industries, Torrent Pharmaceuticals and privately held Emcure Pharmaceuticals, partnered with Merck to expand production of the drug, molnupiravir, hastening its availability in India to address a new wave of infections in the country.